Published in Curr Hypertens Rep on June 01, 2012
Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD). PLoS One (2013) 0.97
Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencing. Nephrol Dial Transplant (2014) 0.85
The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. Clin J Am Soc Nephrol (2015) 0.84
Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes. Br J Pharmacol (2015) 0.82
Association of lower extremity arterial calcification with amputation and mortality in patients with symptomatic peripheral artery disease. PLoS One (2014) 0.82
Interferon-α and the calcifying microangiopathy in Aicardi-Goutières syndrome. Ann Clin Transl Neurol (2015) 0.81
Deregulated Renal Calcium and Phosphate Transport during Experimental Kidney Failure. PLoS One (2015) 0.80
Vascular Calcification and Stone Disease: A New Look towards the Mechanism. J Cardiovasc Dev Dis (2015) 0.80
Osteogenic changes in kidneys of hyperoxaluric rats. Biochim Biophys Acta (2015) 0.76
Calcium as a cardiovascular toxin in CKD-MBD. Bone (2016) 0.76
Gelsolin and Progression of Aortic Arch Calcification in Chronic Hemodialysis Patients. Int J Med Sci (2016) 0.75
Resistance to erythropoiesis-stimulating agents is associated with arterial microcalcification in early hemodialysis patients. Biomed Res Int (2014) 0.75
Osteopontin regulates macrophage activation and osteoclast formation in hypertensive patients with vascular calcification. Sci Rep (2017) 0.75
Calcification of Human Saphenous Vein Associated with Endothelial Dysfunction: A Pilot Histopathophysiological and Demographical Study. Front Surg (2017) 0.75
Hyperphosphatemia. The hidden killer in chronic kidney disease. Saudi Med J (2015) 0.75
Clinical Significance of Pre-Transplant Arterial Stiffness and the Impact of Kidney Transplantation on Arterial Stiffness. PLoS One (2015) 0.75
Vascular calcification and cardiac function according to residual renal function in patients on hemodialysis with urination. PLoS One (2017) 0.75
Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature (1997) 13.77
Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA (2004) 9.99
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int (2002) 9.29
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med (2000) 8.47
Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation (2003) 8.29
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis (1998) 7.79
Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int (2007) 6.34
Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant (2003) 6.15
Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation (2005) 5.29
Phosphate regulation of vascular smooth muscle cell calcification. Circ Res (2000) 5.18
Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation (2007) 4.20
Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res (2006) 3.97
Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol (1996) 3.77
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int (2005) 3.71
Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res (2001) 3.50
Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol (2004) 3.22
Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol (1997) 2.80
FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Osteoporos Int (2011) 2.71
Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem (2008) 2.55
Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study. J Am Coll Cardiol (2010) 2.50
Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation (2002) 2.47
Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation (2008) 2.39
The case against calcium-based phosphate binders. Clin J Am Soc Nephrol (2006) 2.38
Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant (2000) 2.38
Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization. Circ Res (2011) 2.26
Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) Study. Am J Kidney Dis (2011) 2.25
Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int (2004) 2.25
Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/- mice. Arterioscler Thromb Vasc Biol (2007) 2.22
Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation (2000) 2.22
Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. J Am Soc Nephrol (2004) 2.16
Pathophysiology of vascular calcification in chronic kidney disease. Circ Res (2004) 2.16
Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int (2002) 2.03
Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clin J Am Soc Nephrol (2009) 1.95
Coronary artery calcium to predict all-cause mortality in elderly men and women. J Am Coll Cardiol (2008) 1.95
Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol (2007) 1.93
Medial arterial calcification and its association with mortality and complications of diabetes. Diabetologia (1988) 1.91
Natural history of vascular calcification in dialysis and transplant patients. Nephrol Dial Transplant (2004) 1.84
Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem (2000) 1.83
Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int (2002) 1.82
Immunologic function and survival in hemodialysis patients. Kidney Int (1998) 1.82
Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin. Kidney Int (2009) 1.77
Monocyte/macrophage regulation of vascular calcification in vitro. Circulation (2002) 1.67
Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant (2004) 1.61
Activation of vascular bone morphogenetic protein signaling in diabetes mellitus. Circ Res (2010) 1.58
Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol (2009) 1.49
Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease. Semin Dial (2007) 1.42
Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler Thromb Vasc Biol (2007) 1.33
Determinants of coronary artery calcification in diabetics with and without nephropathy. Kidney Int (2004) 1.28
Use of electron beam tomography data to develop models for prediction of hard coronary events. Am Heart J (2001) 1.27
8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway. J Biol Chem (2002) 1.26
Calcified atherosclerosis in different vascular beds and the risk of mortality. Arterioscler Thromb Vasc Biol (2011) 1.25
Vascular calcification and osteoporosis: inflammatory responses to oxidized lipids. Int J Epidemiol (2002) 1.23
Elastin-derived peptides and TGF-beta1 induce osteogenic responses in smooth muscle cells. Biochem Biophys Res Commun (2005) 1.22
Annexin-mediated matrix vesicle calcification in vascular smooth muscle cells. J Bone Miner Res (2008) 1.22
Calcification of coronary intima and media: immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients. Clin J Am Soc Nephrol (2006) 1.22
High-density lipoprotein regulates calcification of vascular cells. Circ Res (2002) 1.22
Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK. J Vasc Res (2009) 1.21
The mechanisms of uremic serum-induced expression of bone matrix proteins in bovine vascular smooth muscle cells. Kidney Int (2006) 1.18
N-3 fatty acids inhibit vascular calcification via the p38-mitogen-activated protein kinase and peroxisome proliferator-activated receptor-gamma pathways. Circ Res (2006) 1.17
High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrol Dial Transplant (2006) 1.15
Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals. Atherosclerosis (2008) 1.13
Angiotensin II and the vascular phenotype in hypertension. Expert Rev Mol Med (2011) 1.11
Calciphylaxis and vascular calcification: a continuum of extra-skeletal osteogenesis. Pediatr Nephrol (2003) 1.11
Novel cardiovascular risk factors in end-stage renal disease. J Am Soc Nephrol (2004) 1.06
Sequential activation of matrix metalloproteinase 9 and transforming growth factor beta in arterial elastocalcinosis. Arterioscler Thromb Vasc Biol (2008) 1.05
Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study. Am J Kidney Dis (2008) 1.05
RAGE axis: Animal models and novel insights into the vascular complications of diabetes. Arterioscler Thromb Vasc Biol (2004) 1.05
Fibroblast growth factor 23 and the future of phosphorus management. Curr Opin Nephrol Hypertens (2009) 1.04
Progression of coronary artery calcification in diabetics with and without chronic kidney disease. Kidney Int (2005) 1.03
Advanced glycation end-products enhance calcification in vascular smooth muscle cells. J Int Med Res (2009) 1.02
Na+-dependent phosphate cotransporters: the NaPi protein families. J Exp Biol (1998) 1.02
Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients. J Clin Invest (1997) 1.01
Immunological basis of inflammation in dialysis. Nephrol Dial Transplant (2002) 0.99
Activation of receptor for advanced glycation end products induces osteogenic differentiation of vascular smooth muscle cells. J Atheroscler Thromb (2011) 0.96
Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients. Hemodial Int (2010) 0.96
The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease. J Bone Miner Res (2012) 0.94
Advanced glycation endproducts accelerate calcification in microvascular pericytes. Biochem Biophys Res Commun (1999) 0.93
Increased lipogenesis and stearate accelerate vascular calcification in calcifying vascular cells. J Biol Chem (2011) 0.92
Changes in common carotid artery intima-media thickness over 1 year in patients on peritoneal dialysis. Nephrol Dial Transplant (2004) 0.91
Elastin degradation accelerates phosphate-induced mineralization of vascular smooth muscle cells. Calcif Tissue Int (2009) 0.91
Association of coronary artery calcium and congestive heart failure in the general population: Results of the Heinz Nixdorf Recall study. Clin Res Cardiol (2010) 0.90
Statins moderate coronary stenoses but not coronary calcification: results from meta-analyses. Int J Cardiol (2010) 0.90
Angiotensin II type 1 receptor blocker inhibits arterial calcification in a pre-clinical model. Cardiovasc Res (2010) 0.89
Activation of arterial matrix metalloproteinases leads to vascular calcification in chronic kidney disease. Am J Nephrol (2011) 0.88
Superoxide production: a procalcifying cell signalling event in osteoblastic differentiation of vascular smooth muscle cells exposed to calcification media. Free Radic Res (2008) 0.87
Verapamil inhibits calcification and matrix vesicle activity of bovine vascular smooth muscle cells. Kidney Int (2009) 0.86
Review article: Getting the balance right: assessing causes and extent of vascular calcification in chronic kidney disease. Nephrology (Carlton) (2009) 0.85
Added value of CAC in risk stratification for cardiovascular events: a systematic review. Eur J Clin Invest (2011) 0.85
Blockage of the renin-angiotensin system attenuates mortality but not vascular calcification in uremic rats: sevelamer carbonate prevents vascular calcification. Am J Nephrol (2009) 0.84
Endogenous aldosterone is involved in vascular calcification in rat. Exp Biol Med (Maywood) (2011) 0.84
Diagnosis of atherosclerosis by imaging. Am J Med (2009) 0.84
Regulation of interleukin-6 expression in osteoblasts by oxidized phospholipids. J Lipid Res (2009) 0.83
Modification of elastin by pentosidine is associated with the calcification of aortic media in patients with end-stage renal disease. Nephrol Dial Transplant (2003) 0.83
Vascular calcification: new insights into an old problem. J Pathol (1998) 0.81
Advanced oxidation protein products induce vascular calcification by promoting osteoblastic trans-differentiation of smooth muscle cells via oxidative stress and ERK pathway. Ren Fail (2009) 0.79
Phosphatidylinositol 3-kinase/Akt pathway regulates inflammatory mediators-induced calcification of human vascular smooth muscle cells. Osaka City Med J (2009) 0.77
The ethnic-specific nature of mechanisms for coronary heart disease. J Am Coll Cardiol (2003) 0.76
Advanced glycation of beta 2-microglobulin in the pathogenesis of bone lesions in dialysis-associated amyloidosis. Nephrol Dial Transplant (1996) 0.75
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med (2012) 8.88
Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med (2004) 6.52
Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis (2005) 2.82
Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease. Kidney Int (2012) 1.86
Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int (2002) 1.82
The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism. Kidney Int (2003) 1.82
Calcimimetic inhibits late-stage cyst growth in ADPKD. J Am Soc Nephrol (2009) 1.58
The case for routine parathyroid hormone monitoring. Clin J Am Soc Nephrol (2012) 1.43
Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview. Clin J Am Soc Nephrol (2007) 1.34
Annexin-mediated matrix vesicle calcification in vascular smooth muscle cells. J Bone Miner Res (2008) 1.22
CKD-mineral and bone disorder: core curriculum 2011. Am J Kidney Dis (2011) 1.20
Direct effects of phosphate on vascular cell function. Adv Chronic Kidney Dis (2011) 1.17
Reimbursement of dialysis: a comparison of seven countries. J Am Soc Nephrol (2012) 1.17
High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrol Dial Transplant (2006) 1.15
Arterial calcification in diabetes. Curr Diab Rep (2003) 1.14
Vascular calcification in dialysis patients: pathogenesis and consequences. Am J Kidney Dis (2003) 1.09
All research does not a guideline make! Am J Kidney Dis (2010) 1.05
Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study. Nephrol Dial Transplant (2007) 1.04
Fetuin-A uptake in bovine vascular smooth muscle cells is calcium dependent and mediated by annexins. Am J Physiol Renal Physiol (2006) 1.04
Worsening endothelial function with efavirenz compared to protease inhibitors: a 12-month prospective study. PLoS One (2012) 1.04
Fish consumption and omega-3 fatty acid status and determinants in long-term hemodialysis. Am J Kidney Dis (2006) 1.03
Effects of switching from efavirenz to raltegravir on endothelial function, bone mineral metabolism, inflammation, and renal function: a randomized, controlled trial. J Acquir Immune Defic Syndr (2013) 1.02
Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial. Nephrol Dial Transplant (2012) 1.01
The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial. J Clin Endocrinol Metab (2013) 0.98
Variation in serum and plasma PTH levels in second-generation assays in hemodialysis patients: a cross-sectional study. Am J Kidney Dis (2008) 0.97
Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD). PLoS One (2013) 0.97
Klotho: a master regulator of cardiovascular disease? Circulation (2012) 0.92
The role of vitamin D in vascular calcification in chronic kidney disease. Semin Dial (2005) 0.91
Optimal vitamin D, calcitriol, and vitamin D analog replacement in chronic kidney disease: to D or not to D: that is the question. Curr Opin Nephrol Hypertens (2011) 0.89
Management of chronic kidney disease mineral-bone disorder. Adv Chronic Kidney Dis (2007) 0.88
Activation of arterial matrix metalloproteinases leads to vascular calcification in chronic kidney disease. Am J Nephrol (2011) 0.88
Transglutaminase 2 accelerates vascular calcification in chronic kidney disease. Am J Nephrol (2013) 0.87
The effect of a diet containing 70% protein from plants on mineral metabolism and musculoskeletal health in chronic kidney disease. Am J Nephrol (2015) 0.86
Verapamil inhibits calcification and matrix vesicle activity of bovine vascular smooth muscle cells. Kidney Int (2009) 0.86
Recent advances in the noninvasive diagnosis of renal osteodystrophy. Kidney Int (2013) 0.85
RhoA/Rho kinase (ROCK) alters fetuin-A uptake and regulates calcification in bovine vascular smooth muscle cells (BVSMC). Am J Physiol Renal Physiol (2010) 0.83
Vascular calcification in chronic kidney disease. Semin Nephrol (2004) 0.83
Calcimimetics inhibit renal pathology in rodent nephronophthisis. Kidney Int (2011) 0.83
Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis. Clin J Am Soc Nephrol (2010) 0.82
Effects of sevelamer hydrochloride and calcium acetate on the oral bioavailability of ciprofloxacin. Am J Kidney Dis (2003) 0.82
Hepatitis C increases the risk of progression of chronic kidney disease in patients with glomerulonephritis. Am J Nephrol (2010) 0.81
Uremic vascular calcification. J Investig Med (2006) 0.80
Signal transduction of beta2m-induced expression of VCAM-1 and COX-2 in synovial fibroblasts. Kidney Int (2002) 0.80
Management of chronic kidney disease-mineral bone disorder. Adv Chronic Kidney Dis (2007) 0.80
Calcification or classification? J Am Soc Nephrol (2005) 0.80
Rebuttal: PTH--a particularly tricky hormone: why measure it at all in kidney patients? Clin J Am Soc Nephrol (2012) 0.80
Vascular calcification: the three-hit model. J Am Soc Nephrol (2009) 0.80
Precision of biomarkers to define chronic inflammation in CKD. Am J Nephrol (2008) 0.78
Adverse mandibular bone effects associated with kidney disease are only partially corrected with bisphosphonate and/or calcium treatment. Am J Nephrol (2013) 0.78
Review article: Chronic kidney disease-mineral bone disorder: have we got the assays right? Nephrology (Carlton) (2009) 0.78
Low Bone Turnover in Chronic Kidney Disease Is Associated with Decreased VEGF-A Expression and Osteoblast Differentiation. Am J Nephrol (2015) 0.77
Gentamicin pharmacokinetics and pharmacodynamics during short-daily hemodialysis. Am J Nephrol (2012) 0.77
(18)F-NaF PET Imaging of Early Coronary Artery Calcification. JACC Cardiovasc Imaging (2015) 0.76
Identity and localization of advanced glycation end products on human beta2-microglobulin using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Biochem (2003) 0.76
Calcitriol Suppression of Parathyroid Hormone Fails to Improve Skeletal Properties in an Animal Model of Chronic Kidney Disease. Am J Nephrol (2016) 0.75
Oral phosphate binders in patients with kidney failure. N Engl J Med (2010) 0.75
The KDIGO guideline on dialysate calcium and patient outcomes: need for hard evidence. Kidney Int (2011) 0.75
Calcium builds strong bones, and more is better--correct? Well, maybe not. Clin J Am Soc Nephrol (2012) 0.75
Disturbances of bone and mineral metabolism in chronic kidney disease: an international initiative to improve diagnosis and treatment. Nephrol Dial Transplant (2004) 0.75
Cellular uptake of beta2M and AGE-beta2M in synovial fibroblasts and macrophages. Nephrol Dial Transplant (2003) 0.75
Research ethics and medical education. Virtual Mentor (2004) 0.75
Medication changes based on echocardiography in dialysis patients. Hemodial Int (2009) 0.75
Introduction. Renal osteodystrophy. Semin Nephrol (2004) 0.75
Children with chronic kidney disease: are they insured as adults? Pediatr Nephrol (2011) 0.75
Healthcare outcomes in undocumented immigrants undergoing two emergency dialysis approaches . Clin Nephrol (2017) 0.75